Seoul National University Hospital
Seoul, 03080, South Korea
NCT Number: NCT05912543
The purpose of this prospective randomized controlled trial is to determine whether using the Oxygen Reserve Index can prevent hyperoxemia in pediatric patients receiving single-lung ventilation.
Participants will have their FiO2 adjusted in a prescribed manner based on the arm to which they are assigned.
The researchers will compare whether blood oxygen levels were lower in the ORI group.
Looking for future studies?
Notify MeUp to 7 year
All sexes
Interventional
Not applicable
Seoul, 03080, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The inhaled oxygen concentration after one-lung ventilation will be treated by the group.
Time frame: 30 minutes after initiation of one-lung ventilation
arterial oxygen content over 200
Time frame: during one lung ventilation
Time frame: during one lung ventilation
Time frame: perioperative period
Time frame: perioperative period
Seoul National University Hospital
Other
A Titration of Fractional Inspired Oxygen Using Oxygen Reserve Index (ORi™) During One-lung Ventilation in the Pediatric Patient: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07369232
Antioxidant, Cerebral Autoregulation
Anderlecht, Brussels Capital, Belgium
View Trial DetailsNCT07549763
CPAP, Hyperoxemia
Edirne, Merkez, Turkey (Türkiye)
View Trial DetailsNCT05505032
Fraction of Inspired Oxygen, Hyperoxemia
Ankara, Cankaya, Turkey (Türkiye)
View Trial DetailsNCT04211246
Hyperoxemia
Seoul, South Korea
View Trial Details